Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ehsan Alimohammadi, Mohammad Khedri, Ahmad Miri Jahromi, Reza Maleki & Milad Rezaian. (2020) Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study. International Journal of Nanomedicine 15, pages 6887-6903.
Read now
Read now
Zahra Zand, Pegah Afarinesh Khaki, Abbas Salihi, Majid Sharifi, Nadir Mustafa Qadir Nanakali, Asaad AB Alasady, Falah Mohammad Aziz, Koorosh Shahpasand, Anwarul Hasan & Mojtaba Falahati. (2019) Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity. International Journal of Nanomedicine 14, pages 6989-7000.
Read now
Read now
Articles from other publishers (16)
Ruirui Qiao, Changkui Fu, Helen Forgham, Ibrahim Javed, Xumin Huang, Jiayuan Zhu, Andrew K. Whittaker & Thomas P. Davis. (2023) Magnetic iron oxide nanoparticles for brain imaging and drug delivery. Advanced Drug Delivery Reviews 197, pages 114822.
Crossref
Crossref
Yatao Pan, Guangjing Hou, Xiaojuan Wang, Xia Ran, Pingan Liu & Lijun Guo. (2023) N, F-doped graphene quantum dots effectively inhibit the fibrillization of amyloid-beta peptide (1–42). Materials Chemistry and Physics 299, pages 127522.
Crossref
Crossref
Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem A Alanezi, Harshita Abul Barkat, Hazrina Ab Hadi, Ranjit K Harwansh & Vineet Mittal. (2023) Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease. Nanomedicine 18:2, pages 145-168.
Crossref
Crossref
Lili Li, Jiajia Zhang, Xiaoyue Huang, Jingguo Du, Zhiqiang Tu, Haotian Wu, Xu Liu & Mingqing Yuan. (2023) Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease. Current Pharmaceutical Design 29:2, pages 95-115.
Crossref
Crossref
Lilian Calderón-Garcidueñas, Elijah W. Stommel, Ingolf Lachmann, Katharina Waniek, Chih-Kai Chao, Angélica González-Maciel, Edgar García-Rojas, Ricardo Torres-Jardón, Ricardo Delgado-Chávez & Partha S. Mukherjee. (2022) TDP-43 CSF Concentrations Increase Exponentially with Age in Metropolitan Mexico City Young Urbanites Highly Exposed to PM2.5 and Ultrafine Particles and Historically Showing Alzheimer and Parkinson’s Hallmarks. Brain TDP-43 Pathology in MMC Residents Is Associated with High Cisternal CSF TDP-43 Concentrations. Toxics 10:10, pages 559.
Crossref
Crossref
Cai-Ling Shen, Yu-Hsuan Wu, Ting-Hao Zhang & Ling-Hsien Tu. (2022) Dihydrocaffeic Acid-Decorated Iron Oxide Nanomaterials Effectively Inhibit Human Calcitonin Aggregation. ACS Omega 7:35, pages 31520-31528.
Crossref
Crossref
Lilian Calderón-Garcidueñas, Angélica González-Maciel, Rafael Reynoso-Robles, Héctor G. Silva-Pereyra, Ricardo Torres-Jardón, Rafael Brito-Aguilar, Alberto Ayala, Elijah W. Stommel & Ricardo Delgado-Chávez. (2022) Environmentally Toxic Solid Nanoparticles in Noradrenergic and Dopaminergic Nuclei and Cerebellum of Metropolitan Mexico City Children and Young Adults with Neural Quadruple Misfolded Protein Pathologies and High Exposures to Nano Particulate Matter. Toxics 10:4, pages 164.
Crossref
Crossref
Nikita Subhash Hinge, Himanshu Kathuria & Murali Monohar Pandey. (2022) Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Applied Materials Today 26, pages 101303.
Crossref
Crossref
Xidong Li, Qiushi Li, Yanhui Zhang, Yang Bai, Yue Cao, Yang Yang, Lie Zang, Meiyi Huang & Rubo Sui. (2021) Nickel oxide nanoparticles increase α-synuclein amyloid formation and relevant overexpression of inflammatory mediators in microglia as a marker of Parkinson's disease. Arabian Journal of Chemistry 14:10, pages 103380.
Crossref
Crossref
Yilan Xu, Manna Zhao, Dongming Zhou, Tingting Zheng & Heng Zhang. (2021) The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy. Biomedicine & Pharmacotherapy 137, pages 111360.
Crossref
Crossref
Jianhang Li, Guanbin Gao, Xintong Tang, Meng Yu, Meng He & Taolei Sun. (2021)
Isomeric Effect of Nano-Inhibitors on Aβ
40
Fibrillation at The Nano-Bio Interface
. ACS Applied Materials & Interfaces 13:4, pages 4894-4904.
Crossref
Crossref
Jingjun Lyu, Xiaobing Long, Tuxiu Xie, Guijun Jiang, Jie Jiang, Lu Ye & Qiongzi Li. (2021) Copper oxide nanoparticles promote α-synuclein oligomerization and underlying neurotoxicity as a model of Parkinson's disease. Journal of Molecular Liquids 323, pages 115051.
Crossref
Crossref
Chao Pang, Na Zhang & Mojtaba Falahati. (2021) Acceleration of α-synuclein fibril formation and associated cytotoxicity stimulated by silica nanoparticles as a model of neurodegenerative diseases. International Journal of Biological Macromolecules 169, pages 532-540.
Crossref
Crossref
Parasuraman Padmanabhan, Mathangi Palanivel, Ajay Kumar, Domokos Máthé, George K. RaddaKah-Leong Lim & Balázs Gulyás. (2020) Nanotheranostic agents for neurodegenerative diseases. Emerging Topics in Life Sciences 4:6, pages 645-675.
Crossref
Crossref
Nafiu Aminu, Idris Bello, Nura Muhammad Umar, Nuhu Tanko, Abdulmalik Aminu & Momoh Mumuni Audu. (2020) The influence of nanoparticulate drug delivery systems in drug therapy. Journal of Drug Delivery Science and Technology 60, pages 101961.
Crossref
Crossref
Shen Luo, Chi Ma, Ming-Qin Zhu, Wei-Na Ju, Yu Yang & Xu Wang. (2020) Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref